Doxorubicin-induced death in neuroblactoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6132, doi. 10.1038/sj.onc.1205879
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2002 AND VI 21 AND IP 39
Results: 16
1
2
The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21[supCIP1/Waf1].
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6123, doi. 10.1038/sj.onc.1205842
- By:
- Publication type:
- Article
3
Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-β[sub1]-dependent pathway.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6113, doi. 10.1038/sj.onc.1205778
- By:
- Publication type:
- Article
4
CAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6101, doi. 10.1038/sj.onc.1205765
- By:
- Publication type:
- Article
5
An atypical caspase-independent death pathway for an immunogenic cancer cell line.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6091, doi. 10.1038/sj.onc.1205738
- By:
- Publication type:
- Article
6
Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6082, doi. 10.1038/sj.onc.1205737
- By:
- Publication type:
- Article
7
Tumor necrosis factor-α in Barrett's oesphagus: a potential novel mechanism of action.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6071, doi. 10.1038/sj.onc.1205731
- By:
- Publication type:
- Article
8
Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6059, doi. 10.1038/sj.onc.1205633
- By:
- Publication type:
- Article
9
Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6049, doi. 10.1038/sj.onc.1205766
- By:
- Publication type:
- Article
10
Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6041, doi. 10.1038/sj.onc.1205878
- By:
- Publication type:
- Article
11
Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6032, doi. 10.1038/sj.onc.1205897
- By:
- Publication type:
- Article
12
Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6017, doi. 10.1038/sj.onc.1205877
- By:
- Publication type:
- Article
13
Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 6007, doi. 10.1038/sj.onc.1205865
- By:
- Publication type:
- Article
14
RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 5998, doi. 10.1038/sj.onc.1205746
- By:
- Publication type:
- Article
15
Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 5990, doi. 10.1038/sj.onc.1205693
- By:
- Publication type:
- Article
16
An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia .
- Published in:
- Oncogene, 2002, v. 21, n. 39, p. 5981, doi. 10.1038/sj.onc.1205767
- By:
- Publication type:
- Article